Clinical Trials Browser

Has results × Kidney Neoplasms × belzutifan × Clear all

NCT04195750 2025-04-29

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Phase 3 Active not recruiting

755 enrolled 28 charts 1 FDA

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04489771 2025-02-11

MK-6482-013

Phase 2 Active not recruiting

154 enrolled 19 charts

Carcinoma, Renal Cell, Kidney Neoplasms